There was an association between age, components of the metabolic syndrome such as diabetes, dyslipidemia, hypertension and some biochemical tests (AST/ALT ratio, GGT, platelet count and fasting glucose) and liver fibrosis in patients with NAFLD. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.